Product Information
IBUPROFEN 400 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0397 per EA under NDC 00904585340. Its NADAC has been published 641 times since Mar 19, 2014.
Strength
400 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904585340
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA075682On Market Since
6/10/2009
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 400 MG TABLET has been published 641 times since Mar 19, 2014, and over the history we have for it it has declined 18.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0397 per EA |
|---|---|
| All-time high | $0.0577 (Sep 15, 2021) |
| All-time low | $0.0336 (Sep 19, 2018) |
| 52-week high | $0.0444 |
| 52-week low | $0.0387 |
| Median price | $0.0470 |
| Average price | $0.0463 |
| Largest weekly change | -25.2% (Nov 20, 2024) |
| Weeks tracked | 641 |
| Tracking since | Mar 19, 2014 |
Generic Alternatives
The matcher finds 14 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IBUPROFEN 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 400 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0397 per EA (NDC 00904585340), effective Jun 24, 2026.
How has the price of IBUPROFEN 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 400 MG TABLET has declined 18.7%. It has been tracked across 641 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 400 MG TABLET?
Since Mar 19, 2014, the NADAC for IBUPROFEN 400 MG TABLET has ranged from a low of $0.0336 (Sep 19, 2018) to a high of $0.0577 (Sep 15, 2021), with a median of $0.0470 per EA.
Are there cheaper alternatives to IBUPROFEN 400 MG TABLET?
14 NADAC-published products share the same active ingredient, strength, and dosage form as IBUPROFEN 400 MG TABLET, but none are currently priced below it.
Who manufactures IBUPROFEN 400 MG TABLET?
IBUPROFEN 400 MG TABLET (NDC 00904585340) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification